Study of the Contribution of Mutant p53/YAP Proteins to Therapy Resistance in Recurrent Head and Neck Cancer

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorRegina Elena Cancer Institute

About this trial

Multicenter, non-interventional, retrospective/prospective study of a biological nature, on patients affected by head and neck tumors, for which the collection and use of tissue samples is planned for the study of the mutational profile, the transcriptional profile and the proteomic profile.

Eligibility criteria

Qualifiers

Age over 18

Patients with squamous cell tumors of the oral cavity, pharynx or larynx

Surgical patients with primary HNSCC tumors, who have not had previous tumors in other sites or adjuvant treatments prior to surgery.

Availability of adequate material (tissue) for the planned analyses

Disqualifiers

Presence of distant metastases at the time of diagnosis

Previous head and neck cancer

Second cancer undergoing treatment or follow-up for less than 5 years

Trial design

Treatments tested in this trial

  • Culture of organoids

Treatment groups

No treatment groups listed

Sponsors and collaborators